-
3
-
-
0034571319
-
Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?
-
DOI 10.1016/S0006-2952(00)00368-3, PII S0006295200003683
-
Borea PA, Dalpiaz A, Varani K, Gilli P, and Gilli G (2000) Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy? Biochem Pharmacol 60:1549-1556. (Pubitemid 30834105)
-
(2000)
Biochemical Pharmacology
, vol.60
, Issue.11
, pp. 1549-1556
-
-
Borea, P.A.1
Dalpiaz, A.2
Varani, K.3
Gilli, P.4
Gilli, G.5
-
6
-
-
0015861774
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
-
Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
-
(1973)
Biochem Pharmacol
, vol.22
, pp. 3099-3108
-
-
Cheng, Y.1
Prusoff, W.H.2
-
7
-
-
0022621697
-
Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. 1. High- And low-affinity states of agonist binding to membrane-bound beta adrenergic receptors
-
Contreras ML, Wolfe BB, and Molinoff PB (1986) Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low affinity states of agonist binding to membrane-bound beta-adrenergic receptors. J Pharmacol Exp Ther 237:154-164. (Pubitemid 16116359)
-
(1986)
Journal of Pharmacology and Experimental Therapeutics
, vol.237
, Issue.1
, pp. 154-164
-
-
Contreras, M.L.1
Wolfe, B.B.2
Molinoff, P.B.3
-
9
-
-
0023838473
-
Thermodynamic analysis of antagonist and agonist interactions with dopamine receptors
-
Duarte EP, Oliveira CR, and Carvalho AP (1988) Thermodynamic analysis of antagonist and agonist interactions with dopamine receptors. Eur J Pharmacol 147:227-239. (Pubitemid 18067197)
-
(1988)
European Journal of Pharmacology
, vol.147
, Issue.2
, pp. 227-239
-
-
Duarte, E.P.1
Oliveira, C.R.2
Carvalho, A.P.3
-
12
-
-
34250195790
-
3-receptor antagonists can be thermodynamically discriminated
-
3-receptor antagonists can be thermodynamically discriminated. Br J Pharmacol 151:504-517.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 504-517
-
-
Harper, E.A.1
Black, J.W.2
-
14
-
-
0030772640
-
International union of pharmacology. XIII. Classification of histamine receptors
-
Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, and Haas HL (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-278. (Pubitemid 27414915)
-
(1997)
Pharmacological Reviews
, vol.49
, Issue.3
, pp. 253-278
-
-
Hill, S.J.1
Ganellin, C.R.2
Timmerman, H.3
Schwartz, J.C.4
Shankley, N.P.5
Young, J.M.6
Schunack, W.7
Levi, R.8
Haas, H.L.9
-
17
-
-
0022475743
-
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors
-
Kilpatrick GJ, el Tayar N, Van de Waterbeemd H, Jenner P, Testa B, and Marsden CD (1986) The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors. Mol Pharmacol 30:226-234.
-
(1986)
Mol Pharmacol
, vol.30
, pp. 226-234
-
-
Kilpatrick, G.J.1
El Tayar, N.2
Van De Waterbeemd, H.3
Jenner, P.4
Testa, B.5
Marsden, C.D.6
-
18
-
-
34447633368
-
Conformational complexity of G-protein-coupled receptors
-
Kobilka BK and Deupi X (2007) Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28:397-406.
-
(2007)
Trends Pharmacol Sci
, vol.28
, pp. 397-406
-
-
Kobilka, B.K.1
Deupi, X.2
-
19
-
-
0028986019
-
1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues
-
1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues. J Med Chem 38:1287-1294.
-
(1995)
J Med Chem
, vol.38
, pp. 1287-1294
-
-
Leschke, C.1
Elz, S.2
Garbarg, M.3
Schunack, W.4
-
22
-
-
67649887142
-
-
Ph.D. dissertation, Free University of Berlin, Berlin, Germany
-
1-Rezeptors. Ph.D. dissertation, Free University of Berlin, Berlin, Germany.
-
(2004)
1-Rezeptors
-
-
Menghin, S.1
-
23
-
-
0037799814
-
1-receptor
-
DOI 10.1124/jpet.103.049619
-
Seifert R, Wenzel-Seifert K, Burckstummer T, Pertz HH, Schunack W, Dove S, Buschauer A, and Elz S (2003) Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor. J Pharmacol Exp Ther 305:1104-1115. (Pubitemid 36617989)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.305
, Issue.3
, pp. 1104-1115
-
-
Seifert, R.1
Wenzel-Seifert, K.2
Burckstummer, T.3
Pertz, H.H.4
Schunack, W.5
Dove, S.6
Buschauer, A.7
Elz, S.8
-
27
-
-
0018607313
-
Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor
-
DOI 10.1038/281114a0
-
Weiland GA, Minneman KP, and Molinoff PB (1979) Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor. Nature 281:114-117. (Pubitemid 9251169)
-
(1979)
Nature
, vol.281
, Issue.5727
, pp. 114-117
-
-
Weiland, G.A.1
Minneman, K.P.2
Molinoff, P.B.3
-
29
-
-
2942589210
-
Order changes within receptor systems upon ligand binding: Receptor tightening/oligomerisation and the interpretation of binding parameters
-
DOI 10.1016/j.jmb.2004.04.056, PII S0022283604005042
-
Williams DH, O'Brien DP, Sandercock AM, and Stephens E (2004) Order changes within receptor systems upon ligand binding: receptor tightening/oligomerisation and the interpretation of binding parameters. J Mol Biol 340:37-383. (Pubitemid 38759916)
-
(2004)
Journal of Molecular Biology
, vol.340
, Issue.2
, pp. 373-383
-
-
Williams, D.H.1
O'Brien, D.P.2
Sandercock, A.M.3
Stephens, E.4
-
30
-
-
0002309097
-
PLS - Partial least squares projection to latent structures
-
(Kubinyi H ed), ESCOM, Leiden
-
Wold S, Johansson A, and Cochi M (1993) PLS - partial least squares projection to latent structures, in 3D QSAR in Drug Design: Theory, Methods and Applications (Kubinyi H ed), p 523-550, ESCOM, Leiden.
-
(1993)
3D QSAR in Drug Design: Theory, Methods and Applications
, pp. 523-550
-
-
Wold, S.1
Johansson, A.2
Cochi, M.3
|